
Fortis healthcare raises $100m from IFC
Indian hospital and diagnostics group Fortis Healthcare is to issue 28.6 million shares to the International Finance Corporation (IFC) for a total of $45 million. Another $55 million will come through a private placement of foreign currency convertible bonds (FCCB), which will have a floor price of INR99.09 ($1.8).
In a filing, the company said the board of directors has also decided to issue between 34.9 million to 45 million fresh shares through an Institutional Placement Programme (IPP) at a face value of INR10 each. The IPP will bring down the promoter's holding to 75% from 81%, to adhere to the Securities and Exchange Board of India's (SEBI) listing norms.
The IFC has previously invested $24.5 million in Fortis' diagnostics chain subsidiary, Super Religare Laboratories (SRL). Last year, Jacob Ballas Capital India committed INR2.5 billion ($44.7 million) to the diagnostic unit, and Sabre Partners and Avigo Capital Partners invested a total of INR1.5 billion in 2011.
Fortis Healthcare has taken a number of measures recently to cut its debt burden, which was INR46 billion ($851 million) as on 30 November, 2012. Last October, the company raised approximately INR22 billion by listing its Religare Health Trust unit on the Singapore Stock Exchange. It is also in the process of selling its Dental Corporation Holdings to BUPA for AUD270 million.
Fortis healthcare operates in India, Hong Kong, Singapore, Vietnam, Dubai, Mauritius, Sri Lanka, Nepal, Australia, New Zealand and Canada with 76 healthcare facilities, over 600 primary care centres, 194 day care speciality centres, over 240 diagnostic centres and around 23,000 staff.
According to a report from consultancy firm RNCOS, the Indian diagnostic market is set for compound annual growth of 26% between 2012 and 2015, on the back of increasing investment, expansion into smaller cities and government support. Meanwhile, the industry is shifting from small, unorganized laboratories into sizeable institutions that provide reliable quality services with a larger range of diagnostic tests.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.